Oxycodone 30 mg

DRUG3 trials

Sponsors

New York State Psychiatric Institute, BioDelivery Sciences International, Tris Pharma, Inc.

Conditions

Opioid-Related DisordersPainRespiratory DepressionSubstance-Related Disorders

Phase 1

Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.

CompletedNCT03996694

BioDelivery Sciences InternationalRespiratory Depression

Start: 2019-07-23End: 2019-10-27Updated: 2021-02-05

Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain.

CompletedNCT05491785

Tris Pharma, Inc.Pain

Start: 2022-07-29End: 2024-01-02Updated: 2024-05-09

Phase 2

Prescription Opioid Effects in Abusers Versus Non-Abusers

CompletedNCT00158184

New York State Psychiatric InstituteOpioid-Related Disorders, Substance-Related Disorders

Start: 2004-06-30End: 2009-06-30Updated: 2017-07-07

Related Papers

Pharmacokinetics of Buprenorphine Buccal Film and Orally-administered Oxycodone in a Respiratory Study: An Analysis of Secondary Outcomes from a Randomized Controlled Trial

Pain and Therapy2022-05-0710 citations

A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory Drive

Advances in Therapy2020-09-2510 citations